Featured Research

from universities, journals, and other organizations

Researchers Find Major Green Tea Ingredient Kills Cancer Cells, Spares Healthy Ones

Date:
December 18, 1997
Source:
Case Western Reserve University
Summary:
In continuing studies of cancer preventing compounds in green tea, researchers at the Case Western Reserve University School of Medicine have found an ingredient that kills cancer cells, while sparing healthy cells.

CLEVELAND - In continuing studies of cancer preventing compounds in green tea, researchers at the Case Western Reserve University School of Medicine have found an ingredient that kills cancer cells, while sparing healthy cells.

Investigators tested the ingredient, called epigallocatechin-3-gallate, on cancerous human and mouse cells of the skin, lymph system, and prostate, and on normal human skin cells. In the test tube, it led to apoptosis, or programmed cell death, in the cancer cells, but left the healthy cells unharmed.

Findings appear in the December 17 issue of the Journal of the National Cancer Institute.

Epigallocatechin-3-gallate is a major constituent of the polyphenols found in green tea. This compound has been shown in previous studies from CWRU and elsewhere to prevent cancer in laboratory animals.

"We found that this particular compound, which is present in the amount of about 200 mg in one cup of green tea, can kill a variety of cancer cells through apoptosis without affecting the normal cells," said Hasan Mukhtar, a professor of dermatology at CWRU and senior author of the paper. The polyphenol broke the DNA of the cancer cells into fragments, a characteristic of apoptosis.

"The killing of cancer cells and the sparing of normal cells is very interesting because apoptosis is a programmed cell death which is a normal process going on in the body all the time. It is a preferential way of elimination of unwanted cells from the body," said Mukhtar.

Polyphenols induce the demise of cancer cells, but scientists do not yet know why this happens, said Mukhtar. "It is likely that this compound conveys a message to cancer cells through a highly ordered and well-regulated signal transduction pathway that says, 'You must commit suicide (programmed cell death) or I am going to kill you.' The cells then decide that instead of being murdered, they will commit suicide," said Mukhtar.

He feels that this finding leads investigators to a greater understanding of the mechanism involved in the process. If they can decipher the molecular mechanism by which green tea imparts protective effects, the knowledge may provide opportunities to interfere with cancer development through administration of purified polyphenolic derivatives, said Mukhtar. "Green tea appears to be potentially an ideal agent for chemoprevention."

The investigators feel that the chemoprevention properties of green tea need to be evaluated in human trials.

Tea consumption in the world ranks second only to water consumption. Approximately 20 percent of tea consumed is green; the rest is black tea.

Other authors on the paper are Nihal Ahmad, Denise K. Feyes, Anna-Liisa Nieminen, and Rajesh Agarwal, all with the CWRU School of Medicine.


Story Source:

The above story is based on materials provided by Case Western Reserve University. Note: Materials may be edited for content and length.


Cite This Page:

Case Western Reserve University. "Researchers Find Major Green Tea Ingredient Kills Cancer Cells, Spares Healthy Ones." ScienceDaily. ScienceDaily, 18 December 1997. <www.sciencedaily.com/releases/1997/12/971218085622.htm>.
Case Western Reserve University. (1997, December 18). Researchers Find Major Green Tea Ingredient Kills Cancer Cells, Spares Healthy Ones. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/1997/12/971218085622.htm
Case Western Reserve University. "Researchers Find Major Green Tea Ingredient Kills Cancer Cells, Spares Healthy Ones." ScienceDaily. www.sciencedaily.com/releases/1997/12/971218085622.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Raw: Elephant Undergoes Surgery in Tbilisi Zoo

Raw: Elephant Undergoes Surgery in Tbilisi Zoo

AP (Sep. 18, 2014) Grand the elephant has successfully undergone surgery to remove a portion of infected tusk at Tbilisi Zoo in Georgia. British veterinary surgeons used an electric drill to extract the infected piece. (Sept. 18) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins